论文部分内容阅读
内镜下黏膜切除术(EMR)及内镜黏膜下剥离术(ESD)逐渐成为一种切除消化道癌前病变与早癌的一种标准微创治疗手段。使用黏膜下注射让黏膜隆起便于切除,有效的黏膜下注射可以减少EMR/ESD的并发症。随着癌前病变与早癌检出率的升高,用于EMR/ESD的技术也在不段完善和提高。现从EMR/ESD的发展对一些新型的黏膜下注射材料进行归纳与阐述,以便寻找理想的黏膜下注射材料。
Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have gradually become a standard minimally invasive treatment for precancerous lesions of the digestive tract and early cancer. Submucosal injections allow mucosal uplift to facilitate resection, and effective submucosal injections can reduce the complications of EMR / ESD. As the precancerous lesion and early cancer detection rate increases, the technology used for EMR / ESD is also not perfect and improve. Now from the development of EMR / ESD some of the new submucosal injection materials summarized and elaborated in order to find the ideal submucosal injection material.